Table 3.
Demographic and Clinical Differences Between Patients Who Participated and Did Not Participate in Neurodevelopmental Testing.a
| Neonates diagnosed with HIE who did not receive ND testing (n = 17) | Neonates diagnosed with HIE who received in ND testing (n = 14) | P | |
|---|---|---|---|
| Male, n | 12 | 7 | .870 |
| Gestational age, wk | 39.50 (1.30) | 38.16 (1.90) | .027* |
| Apgar score, 1 min | 2.53 (2.24) | 2.07 (2.17) | .568 |
| Apgar score, 5 min | 5.47 (2.29) | 3.93 (2.20) | .068 |
| Cord blood pH | 7.01 (0.19) | 7.01 (0.11) | .947 |
| Base deficit | 15.56 (6.30) | 16.59 (5.97) | .691 |
| AED administration, n | 8 | 7 | .870 |
Abbreviations: AED, antiepileptic drug; HIE, hypoxic-ischemic encephalopathy; ND, neurodevelopmental.
a
Data presented include the mean (SD) unless otherwise specified.